Under the banner of a joint research and development, Novo Nordisk and US-based biotech firm 2Seventy Bio will develop a drug candidate for genetic bleeding disorder hemophilia A, reports a press release from 2Seventy Bio.
The partnership builds upon an existing research collaboration between the two companies. Under the terms of the new deal, 2Seventy Bio receives an upfront payment of USD 5m, and the company is eligible for milestone payments of up to USD 35m as well as potential royalties from sales of the drug.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Leo Pharma eczema treatment recommended in two UK countries
After postponing the decision in April, the British medicines council NICE has now ruled that Adtralza can be recommended to treat atopic dermatitis.
Fujifilm invests USD 1.5bn in Danish factory
Japanese firm Fujifilm Diosynth Biotechnologies is investing DKK 11bn (USD 1.5bn) in its factor in Northern Zealand, Denmark. The expansion will provide 450 jobs.
Life science firms are planning USD 6.3bn construction spree in Denmark
Fujifilm’s expansion to its factory in Hillerød means that the life science sector has announced DKK 12bn (USD 1.7bn) in facility investments in Denmark since May.
Sanofi reduces US insulin prices for the uninsured
While bills to introduce a price cap on insulin are being discussed in the US Senate, Sanofi has beaten them to the punch and reduced the price of insulin products for US diabetes patients without insurance.
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Corporate Quality Compliance Specialists 
Nordic Medical Advisor 
Global Product Manager - Pulmonology 
Senior Scientist for Analytical Development 
Chair of the Board 
Key Account Manager Vision Care, Nordic 
Principal Laboratory Technologist Medicinal Chemistry 
Regulatory Affairs Manager - Maternity Cover 
Director Regulatory Affairs 
Open position for a Clinical Trial Manager to join our team at Nykode! 
Senior Manager/Associate Director, Global Regulatory Affairs, CMC 
Project Managers keep all of us healthy